Applying Ozette Discovery™ to CITE-seq data to identify predictors of disease.

Methods such as CITE-seq simultaneously measure RNA and protein expression at a single cell level, but the protein expression data is frequently underutilized. Download our preprint to learn how we harness Ozette Discovery™ to achieve instantaneous in silico sorting of granular cell phenotypes, enabling identification of COVID-19-associated cell populations and precise RNA-seq profiling in mixed samples.


Read More

Ozette announces new partnership with Bloodworks Northwest.

The partnership will allow Bloodworks Northwest subsidiary, Bloodworks Bio, to leverage Ozette’s Lab and proprietary immune cell population discovery and annotation platform. The partnership will facilitate establishing a ‘gold standard’ in the advancement of cell therapies.


Read More

Automated gating and antigen-specific T cells subset discovery using FAUST and COMPASS on ICS data. 

At ISMB 2022, Ozette Computational Biologist Malisa Smith, and Ozette Co-Founder Evan Greene, PhD VP of Quantitative Methods discussed automated gating and antigen-specific T cells subset discovery using FAUST and COMPASS on ICS data as well as how they reanalyzed a published Intracellular Cytokine Staining (ICS) dataset. Download the poster to learn more about their presentation.


Download Poster

A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses.

The engineered outer domain germline targeting version 8 (eOD-GT8) 60-mer nanoparticle was designed to prime VRC01-class HIV-specific B cells that would need to be matured, through additional heterologous immunizations, into B cells that are able to produce broadly neutralizing antibodies. CD4 T cell help will be critical for the development of such high-affinity neutralizing antibody responses. Thus, we assessed the induction and epitope specificities of the vaccine-specific T cells…


Read More